AG Neuroimaging
The "Neuroimaging" working group is part of the Department of Diagnostic and Interventional Radiology and the Department of Nuclear Medicine at Ulm University Hospital.
The working group is concerned with both the application and further development of magnetic resonance imaging (MRI) and molecular imaging using positron emission tomography (PET). Hybrid imaging using PET-MRI in various diseases of the central nervous system (CNS) and the spinal column plays a central role here.
One focus is on the acquisition of multiparametric (including perfusion, diffusion and spectroscopy) and multimodal (combined PET-MRI) image data in the visualisation of biochemical or cellular processes in close correlation with clinical symptoms, including as part of longitudinal imaging in patients with craniocerebral trauma or concussion or neurodegenerative diseases such as Alzheimer's disease with the aid of various receptor-specific radiopharmaceuticals (e.g. synaptic activity or amyloid).
The aim of our research work is to better understand the causes of diseases of the CNS and spine, to improve the imaging detection of diseases and thus also to optimise the treatment and prediction of diseases.